Naturhouse Health, S.A. Stock

Equities

NTH

ES0105043006

Other Specialty Retailers

Delayed BME 06:13:38 2024-04-19 am EDT 5-day change 1st Jan Change
1.67 EUR +0.30% Intraday chart for Naturhouse Health, S.A. -1.18% +3.09%
Sales 2024 * 50M 53.26M Sales 2025 * 51M 54.33M Capitalization 99.82M 106M
Net income 2024 * 10M 10.65M Net income 2025 * 10M 10.65M EV / Sales 2024 * 1.54 x
Net cash position 2024 * 23M 24.5M Net cash position 2025 * 25M 26.63M EV / Sales 2025 * 1.47 x
P/E ratio 2024 *
9.79 x
P/E ratio 2025 *
9.79 x
Employees -
Yield 2024 *
8.41%
Yield 2025 *
8.41%
Free-Float 21.52%
More Fundamentals * Assessed data
Dynamic Chart
Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Naturhouse Health, S.A. (BME: NTH) acquired a 39.58% stake in Indusen Sa from Kiluva S.A. for €3.6 million. CI
Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Naturhouse Health, S.A. acquired 24.8% stake in ICHEM Sp. z o.o. from Zamodiet Sa for ?3.2 million. CI
Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Naturhouse Health, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2019 CI
Naturhouse Health, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2018 CI
Naturhouse Health, S.A. Reports Earnings Results for the First Quarter of 2017 CI
Naturhouse Proposes Final Dividend for 2016, Payable on May 5, 2017 CI
More news
1 day+0.30%
1 week-1.18%
Current month+1.83%
1 month+5.03%
3 months+4.38%
6 months+2.45%
Current year+3.09%
More quotes
1 week
1.61
Extreme 1.605
1.71
1 month
1.59
Extreme 1.585
1.71
Current year
1.55
Extreme 1.55
1.93
1 year
1.55
Extreme 1.55
1.93
3 years
1.51
Extreme 1.51
2.14
5 years
1.16
Extreme 1.155
2.50
10 years
1.16
Extreme 1.155
5.69
More quotes
Managers TitleAgeSince
Chief Executive Officer - 85-12-31
Director of Finance/CFO - 20-12-17
Corporate Secretary - -
Members of the board TitleAgeSince
Director/Board Member - 14-10-07
Director/Board Member 80 16-10-30
Chief Executive Officer - 85-12-31
More insiders
Date Price Change Volume
24-04-19 1.67 +0.30% 7 182
24-04-18 1.665 -0.89% 50,404
24-04-17 1.68 0.00% 36,021
24-04-16 1.68 -1.47% 21,749
24-04-15 1.705 +0.89% 18,923

Delayed Quote BME, April 19, 2024 at 06:13 am EDT

More quotes
Naturhouse Health SA is a Spain-based company primarily engaged in the special foods and wellbeing products manufacture. The Company specializes in developing, manufacturing and selling products within the nutrition, as well as weight management sector. Its activities are divided into three business areas: Food Supplements, which provides products with natural extracts to facilitate the slimming process; Healthy Foods and Drinks, which offers dietary snacks and meals for breakfast; as well as Cosmetics and Body Care, which includes cosmetics for skin treatment during the slimming process. The Company distributes products through a network of own and franchised stores. Furthermore, It operates in Spain, France, Poland, Italy, Mexico, the United Kingdom, and Canada, among others. The Company is a subsidiary of Kiluva SA, as well as controls a number of entities, such as SAS Naturhouse, Kiluva Diet SLU, Zamodiet Mexico SA de CV and Naturhouse Sp z o o.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
1.665
Average target price
-
Consensus

Annual profits - Rate of surprise